UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 72 filers reported holding UROGEN PHARMA LTD in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $88,000 | -49.4% | 5,261 | -54.7% | 0.00% | – |
| Q1 2024 | $174,000 | -43.7% | 11,625 | -43.6% | 0.00% | – |
| Q4 2023 | $309,000 | +29.3% | 20,623 | +21.2% | 0.00% | – |
| Q3 2023 | $239,000 | +42.3% | 17,016 | +4.7% | 0.00% | – |
| Q2 2023 | $168,000 | +14.3% | 16,252 | +2.7% | 0.00% | – |
| Q1 2023 | $147,000 | +11.4% | 15,826 | +6.3% | 0.00% | – |
| Q4 2022 | $132,000 | +6.5% | 14,887 | +0.0% | 0.00% | – |
| Q3 2022 | $124,000 | +1.6% | 14,882 | 0.0% | 0.00% | – |
| Q2 2022 | $122,000 | -12.2% | 14,882 | -7.5% | 0.00% | – |
| Q1 2022 | $139,000 | -17.3% | 16,080 | -9.3% | 0.00% | – |
| Q4 2021 | $168,000 | -46.7% | 17,726 | -5.3% | 0.00% | – |
| Q3 2021 | $315,000 | +12.1% | 18,726 | +1.6% | 0.00% | – |
| Q2 2021 | $281,000 | -86.0% | 18,428 | -82.1% | 0.00% | -100.0% |
| Q1 2021 | $2,011,000 | +15.2% | 103,215 | +6.5% | 0.00% | 0.0% |
| Q4 2020 | $1,746,000 | -11.4% | 96,904 | -5.1% | 0.00% | 0.0% |
| Q3 2020 | $1,970,000 | -26.2% | 102,119 | -0.1% | 0.00% | 0.0% |
| Q2 2020 | $2,669,000 | +48.4% | 102,197 | +1.4% | 0.00% | 0.0% |
| Q1 2020 | $1,799,000 | -47.2% | 100,813 | -1.3% | 0.00% | 0.0% |
| Q4 2019 | $3,409,000 | +630.0% | 102,143 | +420.8% | 0.00% | – |
| Q3 2019 | $467,000 | -27.6% | 19,611 | +9.3% | 0.00% | – |
| Q2 2019 | $645,000 | +45.3% | 17,939 | +48.8% | 0.00% | – |
| Q1 2019 | $444,000 | +56.9% | 12,058 | +83.7% | 0.00% | – |
| Q4 2018 | $283,000 | -20.1% | 6,563 | -12.3% | 0.00% | – |
| Q3 2018 | $354,000 | +17.6% | 7,483 | +23.6% | 0.00% | – |
| Q2 2018 | $301,000 | +19.9% | 6,056 | +19.9% | 0.00% | – |
| Q1 2018 | $251,000 | +79.3% | 5,052 | +34.5% | 0.00% | – |
| Q4 2017 | $140,000 | +154.5% | 3,755 | +114.6% | 0.00% | – |
| Q3 2017 | $55,000 | – | 1,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 1,155,862 | $38,571,000 | 11.13% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 849,478 | $28,347,000 | 4.49% |
| Horton Capital Management, LLC | 108,670 | $3,626,000 | 3.53% |
| Prosight Management, LP | 217,686 | $7,264,000 | 3.19% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $98,598,000 | 2.35% |
| Phoenix Holdings Ltd. | 834,739 | $27,663,000 | 1.16% |
| SHIKIAR ASSET MANAGEMENT INC | 67,025 | $2,237,000 | 0.74% |
| MEITAV INVESTMENT HOUSE LTD | 272,063 | $9,080,000 | 0.66% |
| Clal Insurance Enterprises Holdings Ltd | 17,666 | $529,388,000 | 0.57% |
| Migdal Insurance & Financial Holdings Ltd. | 738,302 | $24,637,000 | 0.48% |